161 IN WITNESS WHEREOF Sample Clauses

161 IN WITNESS WHEREOF the Company has caused this Security to be duly executed, and its corporate seal to be hereunto affixed and attested, all as of the day and year first above written. IRIDIUM, INC. By ---------------------------------- Attest: ------------------------------------
AutoNDA by SimpleDocs
161 IN WITNESS WHEREOF the Trustee has caused this Certificate to be duly executed. Dated: December 27, 1996 BANKERS TRUST COMPANY OF CALIFORNIA, N.A., as Trustee By:_____________________________ Authorized Officer CERTIFICATE OF AUTHENTICATION: This is one of the Class A-1F Certificates referred to in the within named Agreement By:________________________________________________ Authorized Officer of Bankers Trust Company of California, N.A., as Trustee A1F-5 162 EXHIBIT A-1G FORM OF CLASS A-1G CERTIFICATE Date of Pooling and Servicing Original Class A-1G Certificate Agreement and Cut-off Date: Balance: $24,500,000.00 December 1, 1996 First Distribution Date: CUSIP No. 00253C CF 2 January 15, 1997 Denomination: $24,500,000.00 Certificate No.: 1 Class A-1G Pass-Through Rate: 7.32%* AAMES MORTGAGE TRUST 1996-D PASS-THROUGH CERTIFICATE, SERIES 1996-D, CLASS A-1G evidencing a percentage interest in the distributions allocable to the Class A-1G Certificates with respect to a Trust consisting primarily of a pool of conventional, closed-end, fixed and adjustable rate, residential mortgage loans, sold and serviced by Aames Capital Corporation. THIS CERTIFICATE DOES NOT REPRESENT AN OBLIGATION OF OR INTEREST IN AAMES CAPITAL CORPORATION OR THE TRUSTEE REFERRED TO BELOW OR ANY OF THEIR RESPECTIVE AFFILIATES. THIS CERTIFICATE IS NOT A DEPOSIT, AND NEITHER THIS CERTIFICATE NOR THE UNDERLYING MORTGAGE LOANS ARE GUARANTEED OR INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION OR ANY OTHER GOVERNMENTAL AGENCY OR INSTRUMENTALITY. Unless this Certificate is presented by an authorized representative of The Depository Trust Company, a New York Corporation ("DTC"), to Issuer or its agent for registration of transfer, exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as requested by an authorized representative of DTC (and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL in as much as the requested owner hereof, Cede & Co. has an interest herein. * With respect to each Interest Period (as defined in the Agreement) ending prior to the Clean-Up Call Date (as defined in the Agreement) 7.32% per annum and, with respect to each Interest Period ending thereafter, 7.82% per annum.
161 IN WITNESS WHEREOF the Assignor has caused this Supplement to be duly executed as of the day and year first above written. IBJTC LEASING CORPORATION-BSC, as Assignor Its __________________________________ On March ___, 1998, before me, ___________________________, a Notary Public in and for the State of New York, personally appeared ______________________________________________________, personally known to me (or proved to me on the basis of satisfactory evidence) to be the person whose name is subscribed to the within instrument, and acknowledged to me that he or she executed the within instrument in his or her authorized capacity and that, by his or her signature on the within instrument, the person or entity upon behalf of which he or she acted executed the within instrument. WITNESS my hand and official seal. Signature _________________________ (Seal) 163 SCHEDULE 1 [Lease Supplement] 164 SCHEDULE 2 [Description of Property] 165 Consent of Lessee to Supplement to Assignment CONSENT AND ACKNOWLEDGMENT BY LAM XXXEARCH CORPORATION The undersigned hereby acknowledges receipt of a counterpart original of, and consents to, the foregoing Supplement No. __ to the Assignment of Leases and Rents. The foregoing is furnished for good and valuable consideration the receipt and sufficiency of which are hereby acknowledged by the undersigned, and the undersigned understands and intends that the Lenders will rely on the foregoing and that the undersigned will be legally bound by the foregoing. This Consent and Acknowledgment shall inure to the benefit of the Lenders and their respective successors and assigns.
161 IN WITNESS WHEREOF the Assignor and the Assignee have executed this Assignment and Acceptance by their officers thereunto duly authorized as of the date specified below. [NAME OF ASSIGNOR], as Assignor By:______________________________ Title:___________________________ Dated:_______________, __________ [NAME OF ASSIGNEE], as Assignee By:______________________________ Title:___________________________ Dated:_____________ ___, ________ Domestic Lending Office: __________________________________________ __________________________________________ __________________________________________ Eurodollar Lending Office: __________________________________________ __________________________________________ __________________________________________ Accepted this day of _____________, ________ FLEET NATIONAL BANK, as Administrative Agent By:_________________________________________ Title:______________________________________ Consented to this ____ day of _________, ___ TEAM HEALTH, INC. By:_________________________________________ -2- 162 Title:______________________________________ -3- 163 SCHEDULE I TO ASSIGNMENT AND ACCEPTANCE As to the _______________/1/ Facility in respect of which an interest is being assigned: Percentage interest assigned: __________% Assignee's _______________/2/ Commitment: $__________ Aggregate outstanding principal amount of _______________/3/ Advances assigned: $__________ Principal amount of _______________/4/ Note payable to Assignee: $__________ Principal amount of _______________/4/ Note payable to Assignor: $__________ Effective Date (if other than date of acceptance by Administrative Agent): _____, ___ -------------- /1/ Specify Term A Commitments, Term B Commitments or Revolving Credit Commitments here. /2/ Specify Term A Advances, Term B Advances or Revolving Credit Advances here. /3/ Specify Term A Advances, Term B Advances or Revolving Credit Advances here. /4/ Specify Term A Note or Notes, Term B Note or Notes or Revolving Credit Note or Notes here. 164 EXHIBIT B TO THE CREDIT AGREEMENT FORM OF REVOLVING CREDIT PROMISSORY NOTE $_________________ Dated: ________, ____ FOR VALUE RECEIVED, the undersigned, TEAM HEALTH, INC., a Tennessee corporation (the "Borrower"), HEREBY PROMISES TO PAY to the order of ________________________ (the "Lender") for the account of its Applicable Lending Office (as defined in the Credit Agreement referred to below) the aggregate principal amount of the Revolving Credit Advances (as defined below) owing to the Lender by...
161 IN WITNESS WHEREOF each of the undersigned has caused this Agreement to be executed by its official, officer or agent thereunto duly authorized, effective as of ______________, ________. ---------------------------------- -------------------------------- As Assignor As Assignee By: By: ------------------------------- ----------------------------- Name: Name: Title: Title: Percentage Share: % Percentage Share: % ---------------- ------------- Loan Commitment: Loan Commitment: ---------------- -------------- APPROVED: PIONEER NATURAL RESOURCES NATIONSBANK OF TEXAS, N.A. COMPANY By: By: ------------------------------- ----------------------------- Name: Name: Title: Title: [Form of] PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (this "Pledge Agreement"), dated as of ______, 199___, made by ______________________, a __________________ corporation ("Pledgor"), in favor of NATIONSBANK OF TEXAS, N.A., as collateral agent (together with any successor(s) thereto in such capacity, the "Collateral Agent") for each of Lender Parties (as defined below).

Related to 161 IN WITNESS WHEREOF

  • N WITNESS WHEREOF the parties hereto have caused this Agreement to be executed by their respective officers or representatives thereunto duly authorized, as of the date first above written. CATERPILLAR INC. By Name: Xxxxxx X. Xxxxx Title: Treasurer CATERPILLAR FINANCIAL SERVICES CORPORATION By Name: Xxxxx X. Xxxxxxxx Title: Treasurer CATERPILLAR INTERNATIONAL FINANCE LIMITED By Name: Xxxxx X. Xxxxxxxx Title: Director CATERPILLAR FINANCE CORPORATION By Name: Xxxxx X. Xxxxxxxx Title: Director CITIBANK, N.A., as Agent By Name: Title: CITIBANK INTERNATIONAL PLC, as Local Currency Agent By Name: Title: THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., as Japan Local Currency Agent By Name: Title: Banks CITIBANK, N.A. By Name: Title: Domestic Lending Office: Citibank, N.A. 0000 Xxxxx Xx., Building No. 3 New Castle, Delaware 19720 Attention: Xxxxx Xxxxxx Phone: (000) 000-0000 Fax: (000) 000-0000 Eurocurrency Lending Office: Citibank, N.A. 0000 Xxxxx Xx., Building No. 3 New Castle, Delaware 19720 Attention: Xxxxx Xxxxxx Phone: (000) 000-0000 Fax: (000) 000-0000 [BANK] By Name: Title: Domestic Lending Office: [________] [________] [________] Attention: [________] Phone: [________] Fax: [________] Eurocurrency Lending Office: [________] [________] [________] Attention: [________] Phone: [________] Fax: [________] SCHEDULE I COMMITMENTS BANK COMMITMENT REVOLVING CREDIT COMMITMENT Citibank, N.A. $363,000,000.00 $338,500,000.00 Bank of America, N.A. $363,000,000.00 $363,000,000.00 JPMorgan Chase Bank, N.A. $363,000,000.00 $338,500,000.00 Barclays Bank PLC $286,000,000.00 $266,000,000.00 Société Générale $286,000,000.00 $266,000,000.00 The Bank of Tokyo – Mitsubishi UFJ, Ltd. $286,000,000.00 $286,000,000.00 The Royal Bank of Scotland plc $286,000,000.00 $266,000,000.00 Australia and New Zealand Banking Group Limited $176,000,000.00 $176,000,000.00 Xxxxxxx Xxxxx Bank USA $176,000,000.00 $176,000,000.00 Royal Bank of Canada $176,000,000.00 $165,000,000.00 Toronto Dominion (Texas) LLC $176,000,000.00 $176,000,000.00 Commerzbank AG, New York and Grand Cayman Branches $132,000,000.00 $123,500,000.00 BNP Paribas $132,000,000.00 $121,500,000.00 Deutsche Bank AG, New York Branch $132,000,000.00 $132,000,000.00 HSBC Bank USA, National Association $132,000,000.00 $132,000,000.00 ING Bank N.V., Dublin Branch $132,000,000.00 $132,000,000.00 Lloyds TSB Bank plc $132,000,000.00 $124,500,000.00 U.S. Bank National Association $132,000,000.00 $132,000,000.00 Banco Bilbao Vizcaya Argentaria, S.A., New York Branch $110,000,000.00 $110,000,000.00 The Northern Trust Company $99,000,000.00 $99,000,000.00 KBC Bank NV, New York Branch $66,000,000.00 $62,500,000.00 Standard Chartered Bank $66,000,000.00 $66,000,000.00 China Construction Bank Corporation, New York Branch $55,000,000.00 $55,000,000.00 The Bank of New York Mellon $55,000,000.00 $55,000,000.00 Industrial and Commercial Bank of China Limited, New York Branch $44,000,000.00 $44,000,000.00 Westpac Banking Corporation $44,000,000.00 $44,000,000.00 TOTAL $4,400,000,000.00 $4,250,000,000.00 SCHEDULE II COMMITMENT FEE, CDS CAP, CDS FLOOR GRID Basis for Pricing Xxxxx 0 Xxxxx XX Xxxxx XXX Level IV Level V If the long-term senior, unsecured debt of Caterpillar or CFSC, as applicable, is rated at least AA- by Standard & Poor’s or at least Aa3 by Moody’s If the long-term senior, unsecured debt of Caterpillar or CFSC, as applicable, is rated at least A+ by Standard & Poor’s or at least A1 by Moody’s If the long-term senior, unsecured debt of Caterpillar or CFSC, as applicable, is rated at least A by Standard & Poor’s or at least A2 by Moody’s If the long-term senior, unsecured debt of Caterpillar or CFSC, as applicable, is rated at least A- by Standard & Poor’s or at least A3 by Moody’s If the long-term senior, unsecured debt of Caterpillar or CFSC, as applicable, is rated lower than Level IV by Standard & Poor’s and Moody’s Commitment Fee Rate 0.050% 0.060% 0.070% 0.100% 0.150% CDS Floor 0.150% 0.200% 0.250% 0.500% 0.750% CDS Cap 0.750% 0.875% 1.000% 1.250% 1.500% SCHEDULE 4.01(h)

  • IN WITNESS WHEREOF the parties have executed this Agreement as of the date first above written.

  • IN WITNESS WHEROF the parties hereto have caused this Agreement to be executed by their officers thereunto duly authorized as of the date first above written: ATTEST: XXXX XXXXX PROPERTIES, INC. By: By: ATTEST: CORPORATIONS LISTED ON EXHIBIT A HERETO By: By: EXHIBIT A Xxxx Xxxxx Partners Aggressive Growth Fund, Inc. Xxxx Xxxxx Partners Lifestyle Series, Inc. Xxxx Xxxxx Partners Lifestyle Balanced Fund Xxxx Xxxxx Partners Lifestyle Conservative Fund Xxxx Xxxxx Partners Lifestyle Growth Fund Xxxx Xxxxx Partners Lifestyle High Growth Fund Xxxx Xxxxx Partners Lifestyle Income Fund Xxxx Xxxxx Partners Appreciation Fund, Inc. Xxxx Xxxxx Partners Arizona Municipals Fund, Inc. Xxxx Xxxxx Partners California Municipals Fund, Inc. Xxxx Xxxxx Partners Core Plus Bond Fund, Inc. Xxxx Xxxxx Partners Equity Funds Xxxx Xxxxx Partners Social Awareness Fund Xxxx Xxxxx Partners Fundamental Value Fund, Inc. Xxxx Xxxxx Partners Funds, Inc. Xxxx Xxxxx Partners Large Cap Value Fund Xxxx Xxxxx Partners Short-Term Investment Grade Bond Fund Xxxx Xxxxx Partners U.S. Government Securities Fund Xxxx Xxxxx Partners Investment Funds, Inc. Xxxx Xxxxx Partners Government Securities Fund Xxxx Xxxxx Partners Xxxxxxxxxx Global Value Fund Xxxx Xxxxx Partners Investment Grade Bond Fund Xxxx Xxxxx Partners Multiple Discipline Funds All Cap and International Xxxx Xxxxx Partners Multiple Discipline Funds All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Balanced All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Global All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Large Cap Growth and Value Xxxx Xxxxx Partners Real Return Strategy Fund Xxxx Xxxxx Partners Small Cap Growth Fund Xxxx Xxxxx Partners Small Cap Value Fund Xxxx Xxxxx Partners Managed Municipals Fund, Inc. Xxxx Xxxxx Partners New Jersey Municipal Funds, Inc. Xxxx Xxxxx Partners Sector Series, Inc. Xxxx Xxxxx Partners Financial Services Fund Xxxx Xxxxx Partners Health Sciences Fund Xxxx Xxxxx Partners Technology Fund Xxxx Xxxxx Partners Small Cap Core Fund, Inc. Xxxx Xxxxx Partners World Fund, Inc. Xxxx Xxxxx Partners Inflation Management Fund Xxxx Xxxxx Partners International All Cap Growth Fund Xxxx Xxxxx Partners Lifestyle Series, Inc. Xxxx Xxxxx Partners Variable Lifestyle Balanced Portfolio Xxxx Xxxxx Partners Variable Lifestyle Growth Portfolio Xxxx Xxxxx Partners Variable Lifestyle High Growth Portfolio Xxxx Xxxxx Partners Variable Portfolios I, Inc. Xxxx Xxxxx Partners Variable All Cap Portfolio Xxxx Xxxxx Partners Variable High Yield Bond Portfolio Xxxx Xxxxx Partners Variable Investors Portfolio Xxxx Xxxxx Partners Variable Large Cap Growth Portfolio Xxxx Xxxxx Partners Variable Small Cap Growth Portfolio Xxxx Xxxxx Partners Variable Strategic Bond Portfolio Xxxx Xxxxx Partners Variable Total Return Portfolio Xxxx Xxxxx Partners Variable Portfolios III, Inc. Xxxx Xxxxx Partners Variable Adjustable Rate Income Portfolio Xxxx Xxxxx Partners Variable Aggressive Growth Portfolio Xxxx Xxxxx Partners Variable High Income Portfolio Xxxx Xxxxx Partners Variable International All Cap Growth Portfolio Xxxx Xxxxx Partners Variable Large Cap Growth Portfolio Xxxx Xxxxx Partners Variable Large Cap Value Portfolio Xxxx Xxxxx Partners Variable Mid Cap Core Portfolio Xxxx Xxxxx Partners Variable Money Market Portfolio

  • XX WITNESS WHEREOF each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written. FIRST DATA CORPORATION, as Borrower By: Name: Title:

  • IN WITNESS WHERE OF this Agreement has been executed by the parties as at the date first above written. VIBRO-TECH INDUSTRIES, INC. By: /s/ Xxxx XxxXxxxxx Xxxx XxxXxxxxx, Secretary Signed, Sealed and Delivered by Xxxxxxx ) Chow in the presence of: ) ) /s/ Xxxx XxxXxxxxx ) Xxxx XxxXxxxxx ) 000-0000 Xxxx Xxxxxx Xxxxxx ) /s/ Xxxxxxx Xxxx Xxxxxxxxx, X.X. X0X 0X0 ) XXXXXXX XXXX

  • IN WITNESS WHEREFORE the parties have signed this Agreement on the date first written above. COMPANY: HORIZON THERAPEUTICS PLC and HORIZON THERAPEUTICS USA, INC. By: Title: Chairman, President & CEO Print Name: Xxxxxxx X. Xxxxxxx Signature: /s/ Xxxxxxx X. Xxxxxxx As authorized agent of the Company EXECUTIVE: XXXXX XXXXX /s/ Xxxxx Xxxxx Xxxxx Xxxxx, individually EXHIBIT A RELEASE AND WAIVER OF CLAIMS In consideration of the payments and other benefits set forth in Section 4.4 of the Executive Employment Agreement dated , (the “Employment Agreement”), to which this form is attached, I, Xxxxx Xxxxx, hereby furnish Horizon Therapeutics, plc and Horizon Therapeutics USA, Inc. (together the “Company”), with the following release and waiver (“Release and Waiver”). In exchange for the consideration provided to me by the Employment Agreement that I am not otherwise entitled to receive, I hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, Affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring relating to my employment or the termination thereof prior to my signing this Release and Waiver. This general release includes, but is not limited to: (1) all claims arising out of or in any way related to my employment with the Company or the termination of that employment; (2) all claims related to my compensation or benefits from the Company, including, but not limited to, salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including, but not limited to, claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including, but not limited to, claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), the Illinois Human Rights Act, the Illinois Equal Pay Act, the Illinois Religious Freedom Restoration Act, and the Illinois Genetic Information Privacy Act. Notwithstanding the foregoing, this Release and Waiver, shall not release or waive my rights: to indemnification under the articles and bylaws of the Company or applicable law; to coverage under any D&O or other similar insurance policy; to payments under Sections of the Employment Agreement; under any provision of the Employment Agreement that survives the termination of that agreement; under any applicable workers’ compensation statute; under any option, restricted share or other agreement concerning any equity interest in the Company; as a shareholder of the Company or any other right that is not waivable under applicable law. I acknowledge that, among other rights, I am waiving and releasing any rights I may have under ADEA, that this Release and Waiver is knowing and voluntary, and that the consideration given for this Release and Waiver is in addition to anything of value to which I was already entitled as an executive of the Company. If I am 40 years of age or older upon execution of this Release and Waiver, I further acknowledge that I have been advised, as required by the Older Workers Benefit Protection Act, that: (a) the release and waiver granted herein does not relate to claims under the ADEA which may arise after this Release and Waiver is executed; (b) I should consult with an attorney prior to executing this Release and Waiver; and (c) I have twenty-one (21) days from the date of termination of my employment with the Company in which to consider this Release and Waiver (although I may choose voluntarily to execute this Release and Waiver earlier); (d) I have seven (7) days following the execution of this Release and Waiver to revoke my consent to this Release and Waiver; and (e) this Release and Waiver shall not be effective until the seven (7) day revocation period has expired unexercised. If I am less than 40 years of age upon execution of this Release and Waiver, I acknowledge that I have the right to consult with an attorney prior to executing this Release and Waiver (although I may choose voluntarily not to do so); and (c) I have five (5) days from the date of termination of my employment with the Company in which to consider this Release and Waiver (although I may choose voluntarily to execute this Release and Waiver earlier). I acknowledge my continuing obligations under my Confidential Information and Inventions Agreement dated , . Pursuant to the Confidential Information and Inventions Agreement I understand that among other things, I must not use or disclose any confidential or proprietary information of the Company and I must immediately return all Company property and documents (including all embodiments of proprietary information) and all copies thereof in my possession or control. I understand and agree that my right to the payments and other benefits I am receiving in exchange for my agreement to the terms of this Release and Waiver is contingent upon my continued compliance with my Confidential Information and Inventions Agreement. This Release and Waiver, including my Confidential Information and Inventions Agreement dated , , constitutes the complete, final and exclusive embodiment of the entire agreement between the Company and me with regard to the subject matter hereof. I am not relying on any promise or representation by the Company that is not expressly stated herein. This Release and Waiver may only be modified by a writing signed by both me and a duly authorized officer of the Company. Date: By:

  • AS WITNESS WHEREOF the hands of the have hereunto executed this Agreement on the day and year first above written. CYTOMED THERAPEUTICS PTE LTD SIGNED by ) for and on behalf of ) /s/ Choo Chee Kong in the presence of :- ) ………...………………………. Name: Choo Chee Kong Director [*****] [*****] /s/ [*****] THE SUBSCRIBER SIGNED by ) /s/ SHU FAN FXXXX XXX in the presence of :- ) /s/ [*****] [*****] DATED 27 JUNE 2021 RXXXXX XXXXXXXX XXXXX (THE SUBSCRIBER) AND CYTOMED THERAPEUTICS PTE LTD (THE COMPANY) SUBSCRIPTION AGREEMENT RELATING TO SHARES IN THE CAPITAL OF CYTOMED THERAPEUTICS PTE LTD

  • IT WITNESS WHEREOF the parties hereto have caused this Agreement to be executed in their names and on their behalf under their seals by and through their duly authorized officers, as of the day and year first above written. ADVANTUS CORNERSTONE FUND, INC. By -------------------------------------------- Xxxxxxx X. Xxxxxxxx, President Attest ------------------------------------------ Xxxxxxxxx X. Xxxxxxxxx, Treasurer THE MINNESOTA MUTUAL LIFE INSURANCE COMPANY By ---------------------------------------------- Xxxxxx X. Xxxxxxx, Executive Vice President Attest ------------------------------------------ Xxxxxx X. Xxxxxxxxx, Senior Vice President, General Counsel and Secretary ADVANTUS CAPITAL MANAGEMENT, INC. By ---------------------------------------------- Xxxxxxx X. Xxxxxxxx, President Attest ------------------------------------------ Xxxxxxx X. Xxxxxxxx, Second Vice President - Equity Investments SCHEDULE A TO THE SHAREHOLDER AND ADMINISTRATIVE SERVICES AGREEMENT FOR ADVANTUS CORNERSTONE FUND, INC. (As amended July 21, 1999 and effective August 1, 1999) Minnesota Life shall receive, as compensation for its accounting, auditing, legal and other administrative services pursuant to this Agreement, a monthly fee determined in accordance with the following table: Monthly Administrative Services Fee ------------ $6,200.00 The above monthly fees shall be paid to Minnesota Life not later than five days following the end of each calendar quarter in which said services were rendered.

  • IN WITNESS WEREOF the parties have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as of the date and year first written above. COMPANY: NEUROSIGMA, INC. a Delaware corporation By: Name: Title: [Signature Page for Note and Warrant Purchase Agreement] INVESTOR: [NAME] By: Name: Title:

  • WITNESS WHEREOF the parties hereto have caused this Addendum to be executed as of the date first written above. “DEALER MANAGER” BLACKSTONE ADVISORY PARTNERS L.P. By: Name: Title: “DEALER” (Print Name of Dealer) By: Name: Title: SCHEDULE II TO SELECTED DEALER AGREEMENT WITH BLACKSTONE ADVISORY PARTNERS L.P. NAME OF ISSUER: BLACKSTONE REAL ESTATE INCOME TRUST, INC. NAME OF DEALER: SCHEDULE TO AGREEMENT DATED: Dealer hereby authorizes the Dealer Manager or its agent to deposit selling commissions, Servicing Fees, and other payments due to it pursuant to the Selected Dealer Agreement to its bank account specified below. This authority will remain in force until Dealer notifies the Dealer Manager in writing to cancel it. In the event that the Dealer Manager deposits funds erroneously into Dealer’s account, the Dealer Manager is authorized to debit the account with no prior notice to Dealer for an amount not to exceed the amount of the erroneous deposit. Bank Name: Bank Address: Bank Routing Number: Account Number: “DEALER” (Print Name of Dealer) By: Name: Title: Date:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!